注意力缺陷多动障碍 (ADHD) 治疗市场分析及预测(按规模、份额、增长和趋势)2030 年

  • Report Code : TIPRE00003833
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

 

[研究报告] 2022 年 ADHD 治疗市场规模价值 285.9455 亿美元,预计到 2030 年将达到 647.4237 亿美元;预计 2022-2030 年期间的复合年增长率为 10.8%。 

 

市场洞察和分析师观点:

注意力缺陷多动障碍 (ADHD) 是一种复杂的神经发育障碍,会影响个人的专注力、控制冲动行为和管理多动症的能力。该病大多在儿童时期诊断出来,但症状可能会持续到青少年和成年期。ADHD 的治疗通常涉及多学科方法,包括行为疗法、教育和药物治疗(如兴奋剂和非兴奋剂)。

ADHD 患病率的不断上升以及治疗药物需求的激增等因素推动了市场的增长。然而,ADHD 药物的副作用及其有限的缓解效果阻碍了ADHD 治疗市场的增长。

 

增长动力和限制因素:

 

根据美国疾病控制与预防中心 (CDC) 于 2022 年 2 月发表的文章,美国约有 600 万名 3-17 岁儿童被诊断患有 ADHD,占 2016 年至 2019 年人口的 9.8%。此外,根据 PubMed Central 于 2022 年发表的一篇文章,ADHD 影响了全球 5-7.2% 的儿童和 2.5-6.7% 的成年人。根据最近的估计,美国青少年的发病率要高得多,约为 8.7% 或 530 万人。尽管传统上认为这是一种儿童疾病,但多达 90% 的 ADHD 儿童在成年后仍会出现症状。一项研究表明,在成人中也可以诊断出来,因为 75% 的 ADHD 患者在童年时期没有被诊断出来。ADHD 经常与焦虑、抑郁、学习障碍和药物滥用等并发症有关。这些合并症的存在增加了治疗的复杂性,需要采取多维度的方法,既要治疗 ADHD 症状,又要治疗相关疾病。建议使用精神兴奋剂和非兴奋剂等药物,这些药物可以帮助儿童在日常生活中控制 ADHD 症状,并有助于调节可能导致他们生活各个方面出现困难的行为,包括个人生活和学业成绩。因此,上述因素增加了对治疗 ADHD 的药物的需求,促进了 ADHD 治疗市场份额的扩大。

然而,由于症状缓解有限以及使用治疗药物产生的副作用,ADHD 治疗市场的增长受到限制。精神兴奋剂药物的常见副作用包括食欲下降、失眠、焦虑加剧、易怒、胃痛和头痛。当药物效果消失时,ADHD 症状可能会复发,从而导致“反弹”效应,并且可能更加强烈。

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

注意力缺陷多动障碍 (ADHD) 治疗市场: Therapeutics Market:

ADHD Therapeutics Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

报告细分和范围:

“ADHD 治疗市场分析”通过考虑以下细分领域来进行:药物类型、年龄组和分销渠道。

 

  • 这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

 

节段分析:

根据药物类型,ADHD 治疗市场分为兴奋剂药物和非兴奋剂药物。

兴奋剂药物领域在 2022 年占据了更大的 ADHD 治疗市场份额,预计在 2022-2030 年期间将实现更高的复合年增长率。

 

ADHD 治疗市场(按药物类型)——2022 年和 2030 年

 

ADHD Therapeutics Market
ADHD Therapeutics Market
  • 这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

根据年龄组,ADHD 治疗市场分为儿童和青少年以及成人。儿童和青少年部分在 2022 年占据了更大的市场份额。成人部分预计在 2022 年至 2030 年期间将实现更高的复合年增长率。

就分销渠道而言,ADHD 治疗市场分为医院药房、零售药房和电子商务。2022 年,医院药房占据最大市场份额,预计在 2022-2030 年期间将实现最高复合年增长率。

 

区域分析:

北美、欧洲、亚太地区、南美和中美以及中东和非洲是 ADHD 治疗市场报告范围的主要分析区域。

2022 年,北美占据全球最大市场份额。在北美,美国在 2022 年占据了最大的市场份额,预计在 2022 年至 2030 年期间将继续占据主导地位。ADHD 治疗市场的增长很大程度上是由于美国 ADHD 患病率高。根据 Cingulate 的数据,2022 年约有 640 万名 4 至 17 岁的儿童和青少年被诊断患有 ADHD。其中,该群体中超过 80% 的人接受了治疗,约 65% 的人成年后仍会出现 ADHD 症状。此外,患者负担能力的提高、有利的报销政策以及对现有药物的认识提高预计将推动市场增长。

亚太地区是 ADHD 增长最快的市场,这得益于该地区的主要参与者以及为开发和营销新产品而采取的多项战略举措。例如,2020 年 6 月,大塚制药株式会社和大塚制药开发与商业化有限公司报告了其两项为期六周的 3 期临床试验的积极结果,这些试验评估了口服西他那法定的有效性、安全性和耐受性。西他那法定是一种新型实验药物,旨在治疗被诊断为 ADHD 的成年患者。该公司还计划研究西他那法定对 ADHD 儿童的影响,并与美国食品药品监督管理局讨论下一步行动。

 

行业发展和未来机遇:

ADHD 治疗市场预测可以帮助该市场的利益相关者规划其增长战略。市场主要参与者采取的举措如下:

  1. 2023 年 9 月,Cingulate Inc. 公布了其主要候选药物 CTx-1301(右哌甲酯)治疗 ADHD 的成人疗效和安全性的 3 期研究结果。该公司利用其专利药物输送平台技术精准定时释放 (PTR) 来构建和推进下一代医药产品线。该结果于 9 月 8 日在田纳西州纳什维尔举行的第 36 届年度心理学大会上公布。
  2. 2022年3月,久光制药株式会社的全资子公司Noven Pharmaceuticals, Inc.的XELSTRYM(右旋安非他明)透皮系统CII获得美国食品药品监督管理局(FDA)批准,用于治疗成人和6岁以上儿科患者的ADHD。
  3. 2021 年 7 月,Corium, Inc. 推出了 AZSTARYS。这种创新药物在美国结合了 Serdexmethylphenidate (SDX) 和 dexmethylphenidate (d-MPH),用于 6 岁及以上患者的对症治疗。AZSTARYS 于 2021 年 3 月获得 FDA 批准。它由两种药物组合而成:70% 的 d-MPH SDX 缓释前药(附表 IV)和 30% 的 d-MPH 速释(附表 II)。
  4. 2021年4月,Supernus Pharmaceuticals, Inc.宣布美国FDA批准了Qelbree(维洛沙嗪缓释胶囊),用于治疗6-17岁患者的ADHD。

 

竞争格局和重点公司:

 

Amneal Pharmaceuticals, Inc.、Novartis AG、Pfizer, Inc.、Eli Lilly and Company、Noven Pharmaceuticals, Inc.、Janssen Pharmaceuticals, Inc.、Johnson & Johnson Services, Inc.、Corium Inc、Adlon Therapeutics LP 和 Teva Pharmaceutical Industries Ltd. 是 ADHD 治疗市场报告中介绍的主要参与者。这些公司采用产品开发策略来满足日益增长的客户需求,这使他们能够保持自己的品牌名称。

ADHD 治疗报告范围

报告属性细节
2022 年市场规模285.9455 亿美元
2030 年的市场规模647.4237亿美元
全球复合年增长率(2022 - 2030 年)10.8%
史料2020-2022
预测期2022-2030
涵盖的领域按药物类型
  • 兴奋剂和非兴奋剂
按年龄组
  • 儿童、青少年和成人
分销渠道
  • 医院药房
  • 零售药店
  • 电子商务
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • Amneal 制药公司
  • 诺华公司
  • 辉瑞公司
  • 礼来公司
  • Noven Pharmaceuticals, Inc.
  • 杨森制药公司
  • 强生服务公司
  • 科瑞姆公司
  • Adlon 治疗公司
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What was the estimated size of the ADHD Therapeutics market in 2022?

The digital health market was valued at US$ 28,594.55 billion in 2022.

Which drug type segment dominates the ADHD Therapeutics market?

The ADHD Therapeutics market, by drug type, is segmented into stimulants and non-stimulant drugs. The stimulant drug segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR during 2022-2030.

Which end-user segment dominates the ADHD Therapeutics market?

The ADHD Therapeutics market, by end-user, is segmented into hospitals and clinics, providers, payers, and others. In 2022, the hospitals and clinics segment held the largest market share, and the same segment is anticipated to register the highest CAGR during 2022–2030.

What is ADHD?

Attention deficit/hyperactivity disorder (ADHD) is a complex neurodevelopment disorder that affects individuals’ ability to focus, control impulsive behaviors, and manage hyperactivity. It is mostly diagnosed in childhood, but symptoms can persist into adolescence and adulthood. Treatment for ADHD often involves a multidisciplinary approach, including behavioral therapy, education, and medication such as stimulants and non-stimulants.

Who are the major players in the ADHD Therapeutics market?

The digital health market majorly consists of the players, including Amneal Pharmaceuticals, Inc.; Novartis AG; Pfizer, Inc.; Eli Lilly and Company; Noven Pharmaceuticals, Inc.; Janssen Pharmaceuticals, Inc.; Johnson & Johnson Services, Inc.; Corium Inc; Adlon Therapeutics LP; and Teva Pharmaceutical Industries Ltd. are among the key players profiled in the ADHD therapeutics market.

What factors drive the ADHD Therapeutics market?

Key factors driving the increasing prevalence of ADHD, combined with the increased demand for drugs for treatment, is propelling the market.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies - ADHD Therapeutics Market

  1. Amneal Pharmaceuticals, Inc
  2. Novartis AG
  3. Pfizer, Inc.
  4. Eli Lilly And Company
  5. Noven Pharmaceuticals, Inc.
  6. Janssen Pharmaceuticals, Inc
  7. Johnson & Johnson Services, Inc.
  8. Corium Inc
  9. Adlon Therapeutics L.P
  10. Teva Pharmaceutical Industries Ltd

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.